Home
Science
Mocravimod
Acute Myeloid Leukemia & Hematopoietic Cell Transplantation
CAR T Cells
Our Pipeline
Publications
MO-TRANS
Press
About
Our Leadership Team
Advisory Board
Investors
Our Partners
ESG and Recognition
Contact
Select Page
LSX – Investival Showcase
by
admin
|
Oct 10, 2024
|
Events
Search for:
Recent Posts
Priothera accélère sur son traitement des cancers hématologiques
Priothera accélère sur son traitement des cancers hématologiques
Priothera, la start-up Florent de Saint-Louis qui se rêve licorne
Pniothera pounsuit sa levée de fonds pour accélérer son traitement des cancens hématologiques
Priothera receives a European Union grant of nearly € 685.000 for the development of its innovative treatment for hematologic cancers
Recent Comments
Priothera to start Phase IIb/III trial of acute myeloid leukaemia therapy
on
Priothera Receives FDA clearance of Investigational New Drug (IND)
FDA grants orphan drug designation to mocravimod for acute myeloid leukemia - Healio - The Online Chemists
on
Priothera – FDA and EMA Grant Orphan Drug Designation to mocravimod for the treatment of Acute Myeloid Leukemia (AML) in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT)
Recent Comments